b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2204037/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Optimal design and validation of antiviral siRNA for targeting HIV-1</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2204037/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Retrovirology" /><meta name="citation_title" content="Optimal design and validation of antiviral siRNA for targeting HIV-1" /><meta name="citation_authors" content="Yuki Naito, Kyoko Nohtomi, Toshinari Onogi, Rie Uenishi, Kumiko Ui-Tei, Kaoru Saigo, Yutaka Takebe" /><meta name="citation_date" content="2007" /><meta name="citation_volume" content="4" /><meta name="citation_doi" content="10.1186/1742-4690-4-80" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2204037/?report=abstract" /><meta name="citation_pmid" content="17996047" /><meta name="DC.Title" content="Optimal design and validation of antiviral siRNA for targeting HIV-1" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Yuki Naito" /><meta name="DC.Contributor" content="Kyoko Nohtomi" /><meta name="DC.Contributor" content="Toshinari Onogi" /><meta name="DC.Contributor" content="Rie Uenishi" /><meta name="DC.Contributor" content="Kumiko Ui-Tei" /><meta name="DC.Contributor" content="Kaoru Saigo" /><meta name="DC.Contributor" content="Yutaka Takebe" /><meta name="DC.Date" content="2007" /><meta name="DC.Identifier" content="10.1186/1742-4690-4-80" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Optimal design and validation of antiviral siRNA for targeting HIV-1" /><meta property="og:type" content="article" /><meta property="og:description" content="We propose rational designing of antiviral short-interfering RNA (siRNA) targeting highly divergent HIV-1. In this study, conserved regions within HIV-1 genomes were identified through an exhaustive computational analysis, and the functionality of siRNAs ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2204037/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2204037/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2204037/pdf/12977_2007_Article_809.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A34FAE999BF41000000000B360B34.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC2204037</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">Retrovirology</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Retrovirology</span>. 2007; 4: 80. </span></div><div><span class="fm-vol-iss-date">Published online 2007 Nov 8. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1742-4690-4-80" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1742-4690-4-80</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2204037</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/17996047">17996047</a></div></div></div></div><h1 class="content-title">Optimal design and validation of antiviral siRNA for targeting HIV-1</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Naito%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047" class="affpopup" co-rid="_co_idm140168868682528" co-class="co-affbox">Yuki Naito</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup> <a href="/pubmed/?term=Nohtomi%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047" class="affpopup" co-rid="_co_idm140168866360784" co-class="co-affbox">Kyoko Nohtomi</a>,<sup>2</sup> <a href="/pubmed/?term=Onogi%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047" class="affpopup" co-rid="_co_idm140168868678384" co-class="co-affbox">Toshinari Onogi</a>,<sup>2</sup> <a href="/pubmed/?term=Uenishi%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047" class="affpopup" co-rid="_co_idm140168858795360" co-class="co-affbox">Rie Uenishi</a>,<sup>2</sup> <a href="/pubmed/?term=Ui-Tei%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047" class="affpopup" co-rid="_co_idm140168858792992" co-class="co-affbox">Kumiko Ui-Tei</a>,<sup>1</sup> <a href="/pubmed/?term=Saigo%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047" class="affpopup" co-rid="_co_idm140168858790624" co-class="co-affbox">Kaoru Saigo</a>,<sup>1</sup> and  <a href="/pubmed/?term=Takebe%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047" class="affpopup" co-rid="_co_idm140168861214544" co-class="co-affbox">Yutaka Takebe</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>2</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140168868682528"><h3 class="no_margin">Yuki Naito</h3><p><sup>1</sup>Department of Biophysics and Biochemistry, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan </p><div>Find articles by <a href="/pubmed/?term=Naito%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047">Yuki Naito</a></div></div><div id="_co_idm140168866360784"><h3 class="no_margin">Kyoko Nohtomi</h3><p><sup>2</sup>Laboratory of Molecular Virology and Epidemiology, AIDS Research Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640 Japan </p><div>Find articles by <a href="/pubmed/?term=Nohtomi%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047">Kyoko Nohtomi</a></div></div><div id="_co_idm140168868678384"><h3 class="no_margin">Toshinari Onogi</h3><p><sup>2</sup>Laboratory of Molecular Virology and Epidemiology, AIDS Research Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640 Japan </p><div>Find articles by <a href="/pubmed/?term=Onogi%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047">Toshinari Onogi</a></div></div><div id="_co_idm140168858795360"><h3 class="no_margin">Rie Uenishi</h3><p><sup>2</sup>Laboratory of Molecular Virology and Epidemiology, AIDS Research Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640 Japan </p><div>Find articles by <a href="/pubmed/?term=Uenishi%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047">Rie Uenishi</a></div></div><div id="_co_idm140168858792992"><h3 class="no_margin">Kumiko Ui-Tei</h3><p><sup>1</sup>Department of Biophysics and Biochemistry, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan </p><div>Find articles by <a href="/pubmed/?term=Ui-Tei%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047">Kumiko Ui-Tei</a></div></div><div id="_co_idm140168858790624"><h3 class="no_margin">Kaoru Saigo</h3><p><sup>1</sup>Department of Biophysics and Biochemistry, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan </p><div>Find articles by <a href="/pubmed/?term=Saigo%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047">Kaoru Saigo</a></div></div><div id="_co_idm140168861214544"><h3 class="no_margin">Yutaka Takebe</h3><p><sup>2</sup>Laboratory of Molecular Virology and Epidemiology, AIDS Research Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640 Japan </p><div>Find articles by <a href="/pubmed/?term=Takebe%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17996047">Yutaka Takebe</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140168861107408_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140168861107408_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140168861107408_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140168861107408_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup>1</sup>Department of Biophysics and Biochemistry, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan </div><div class="fm-affl" lang="en" id="Aff2"><sup>2</sup>Laboratory of Molecular Virology and Epidemiology, AIDS Research Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640 Japan </div><div><span class="fm-affl">Yuki Naito, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.iANR@otian-y" class="oemail">pj.iANR@otian-y</a></span>.</div><div><a href="#idm140168861107408aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140168861107408_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2007 Aug 6; Accepted 2007 Nov 8.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140168861107408_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Naito et al; licensee BioMed Central Ltd. 2007</div><div class="license half_rhythm">This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/2.0" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/2.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2204037/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2>Associated Data</h2><dl data-count="7" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Additional file 1: The list of 495 near full-length genome sequences of HIV-1 group M. (PDF 56 KB)</div><div><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl">12977_2007_809_MOESM1_ESM.pdf</a><span style="color:gray"> (56K)</span></div><div class="small guid">GUID:\xc2\xa0FBDBD75B-A3F5-4DFF-8CED-66C2EE7BB6BB</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Additional file 2: The list of published siRNA/shRNAs targeting HIV-1. (PDF 101 KB)</div><div><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl">12977_2007_809_MOESM2_ESM.pdf</a><span style="color:gray"> (101K)</span></div><div class="small guid">GUID:\xc2\xa01B47734F-9C29-43DB-B002-1433FC155821</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Additional file 3: The list of highly conserved siRNA targets identified in this study. (PDF 44 KB)</div><div><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl">12977_2007_809_MOESM3_ESM.pdf</a><span style="color:gray"> (44K)</span></div><div class="small guid">GUID:\xc2\xa08D196302-5240-407D-AEDE-E66A721A71C7</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Additional file 4: The siRNA sequences and their target sites. The sequences of 41 siRNAs and their target sites are shown. The siRNA numbers indicate the nucleotide position in HXB2 (GenBank K03455). The conservation level of each siRNA in HIV-1 group M sequence is depicted in color chart at the rightmost column. BMH (branched multiple hairpin) and LDI (long distance interaction) conformations of the HIV-1 leader RNA and siRNAs targeting them are shown. (PDF 34 KB)</div><div><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM4_ESM.pdf" data-ga-action="click_feat_suppl">12977_2007_809_MOESM4_ESM.pdf</a><span style="color:gray"> (34K)</span></div><div class="small guid">GUID:\xc2\xa0B2B3C0A8-1825-4285-958B-92629BD96A2A</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Additional file 5: Supplementary materials and methods. (PDF 40 KB)</div><div><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM5_ESM.pdf" data-ga-action="click_feat_suppl">12977_2007_809_MOESM5_ESM.pdf</a><span style="color:gray"> (40K)</span></div><div class="small guid">GUID:\xc2\xa071BBF111-0FDC-4018-B3CB-0B04DA132FF4</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Additional file 6: Target sites of the 41 siRNAs used in this study. Sequence alignment of the target site from the four HIV-1 infectious molecular clones: pNL4-2 (subtype B); 95MM-yIDU106 (subtype B\'); 93IN101 (subtype C); or 93JP-NH1 (CRF01_AE). (PDF 22 KB)</div><div><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM6_ESM.pdf" data-ga-action="click_feat_suppl">12977_2007_809_MOESM6_ESM.pdf</a><span style="color:gray"> (22K)</span></div><div class="small guid">GUID:\xc2\xa05D8DEA1D-28EC-4D5E-B03B-3C866A38D58E</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Additional file 7: Coverage of HIV-1 group M by single siRNA or two siRNAs. (A) Coverage of HIV-1 group M by 41 siRNAs used in this study. (B) Coverage of HIV-1 group M by combining two siRNAs from above. Coverage was calculated by considering only the HIV-1 sequences which contain the corresponding regions. (PDF 17 KB)</div><div><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM7_ESM.pdf" data-ga-action="click_feat_suppl">12977_2007_809_MOESM7_ESM.pdf</a><span style="color:gray"> (17K)</span></div><div class="small guid">GUID:\xc2\xa09F125017-F9EE-457A-A4C6-3D8FD9289E84</div></div></dd></dl></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><p id="__p1" class="p p-first">We propose rational designing of antiviral short-interfering RNA (siRNA) targeting highly divergent HIV-1. In this study, conserved regions within HIV-1 genomes were identified through an exhaustive computational analysis, and the functionality of siRNAs targeting the highest possible conserved regions was validated. We present several promising antiviral siRNA candidates that effectively inhibited multiple subtypes of HIV-1 by targeting the best conserved regions in pandemic HIV-1 group M strains.</p><div id="__sec1" class="sec"><h3 id="__sec1title">Electronic supplementary material</h3><p id="__p2" class="p p-first-last">The online version of this article (doi:10.1186/1742-4690-4-80) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Infectious Molecular Clone, Polypurine Tract, Nucleotide Sequence Level, Effective siRNAs, Viral Mutational Escape</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Findings</h2><p id="__p3" class="p p-first">RNA interference (RNAi) is now widely used to knockdown gene expression in a sequence-specific manner, making it a powerful tool not only for studying gene function, but also for therapeutic applications including antiviral treatments [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351209">1</a>, <a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351220">2</a>]. The replication of a wide range of viruses can be successfully inhibited using RNAi with both short interfering RNA (siRNA) and siRNA expression vectors [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351224">3</a>, <a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351213">4</a>]. However, for RNA viruses such as HIV-1, designing functional siRNAs that target viral sequences is problematic because of their extraordinarily high genetic diversity. We analyzed 495 entries of near full-length HIV-1 group M sequences available in the Los Alamos HIV Sequence Database, and selected the highest-possible conserved target sites for designing optimal antiviral siRNAs. It is known that RNAi-resistant viral mutants emerge rapidly when targeting viral sequences due to their high mutation rate [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351221">5</a>&#x02013;<a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351216">7</a>]. Since highly conserved sequences are likely to contain structurally or functionally constrained elements, our approach is anticipated to resist viral mutational escape.</p><p id="__p4">First, we performed a detailed analysis on the HIV-1 genome to identify highly conserved targets by using 495 near full-length genome sequences of HIV-1 group M (listed in Additional file <a href="#MOESM1" rid="MOESM1" class=" media">1</a>). Every possible 21-mer was generated from all of the HIV-1 group M sequences, and their conservations among the 495 HIV-1 sequences were exhaustively determined using siVirus engine [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351229">8</a>]. We defined \'conservation\' as the percentage of sequence entries out of the 495 HIV-1 sequences that showed perfect identity (<em>i.e</em>., 21/21 matches) with the cognate 21-mer. Since many of the HIV-1 sequence entries lack 5\' untranslated region (5\' UTR), the 3\' LTR sequence was used to compensate for the lack of 5\' LTR sequences in order to avoid underestimating conservation in such regions. For the regions that cannot be compensated for in this way (depicted in Figure <a href="/pmc/articles/PMC2204037/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure1A</span></span><span>1A</span></a> and <a href="/pmc/articles/PMC2204037/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and1B</span></span><span>1B</span></a> left panel, colored black), conservation was calculated by considering only the HIV-1 sequences that contain the corresponding regions. The result revealed that HIV-1 genomes are not conserved for consecutive 21 bp for the most part, resulting in the poor conservation of many of the 21-mers over the HIV-1 sequences (Figure <a href="/pmc/articles/PMC2204037/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure1A,</span></span><span>1A</span></a>, colored blue). As shown in Figure <a href="/pmc/articles/PMC2204037/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure1C,</span></span><span>1C</span></a>, only 5.2% of the possible 21-mers are &#x0003e;50% conserved. Furthermore, highly (&#x0003e;70%) conserved 21-mers constitute only 1.6% of all 21-mers. It is of note that many of the published anti-HIV-1 siRNA sequences do not fall into this \'highly conserved\' category (Additional file <a href="#MOESM2" rid="MOESM2" class=" media">2</a> and [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351225">9</a>]). From these results, we anticipate that most of the possible siRNAs are not suitable for the efficient targeting of HIV-1.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC2204037/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140168867336272" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12977_2007_Article_809_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12977_2007_Article_809_Fig1_HTML.jpg" src="/pmc/articles/PMC2204037/bin/12977_2007_Article_809_Fig1_HTML.jpg" /></div><div id="largeobj_idm140168867336272" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2204037/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC2204037/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p5"><strong>Conservations of siRNA target sequences among HIV-1 group M</strong>. (<strong>A</strong>) A total of 4,417,157 siRNA targets were generated from the 495 HIV-1 sequences, and their conservations within the HIV-1 genomes are represented using a color density plot. The line plot above the color chart represents the highest value in each position. (<strong>B</strong>) A detailed view of the three conserved regions; 5\' LTR, the cPPT/CTS in the integrase gene, and 3\' PPT. \'Position\' indicates the 5\'-most position of each 21-mer. The landmarks of the HIV-1 genome are adjusted to align at the center of the siRNAs by shifting 10 bp to the left. (<strong>C</strong>) Pie chart indicating the percentage of the 4,417,157 siRNA target sites at each conservation level.</p></div></div></div><p id="__p6">However, our analysis has identified several distinct regions that are highly conserved in the HIV-1 genome (Figure <a href="/pmc/articles/PMC2204037/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure1B).</span></span><span>1B</span></a>). Such regions include the regulatory domains responsible for the viral gene expression, such as the TATA sequence and polyadenylation signal (AAUAAA). In addition, several regions essential for the regulation of viral replication were also highly conserved, including the primer activation signal (PAS)[<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351223">10</a>], primer binding site (PBS), packaging signal (&#x003a8;), central polypurine tract (cPPT), central termination sequence (CTS), and 3\' polypurine tract (3\' PPT). All of these highly conserved sequences are constrained at the nucleotide sequence level or by their RNA secondary structure in order to execute their functions. In contrast, regions constrained by amino acid sequences were not necessarily conserved at the nucleotide sequence level due to the wobbling of the third base in the codon (data not shown). siRNAs targeting the highly conserved regions are expected to overwhelm the high level of sequence diversity of the HIV-1 genome, and also to reduce the chances of viral mutational escapes.</p><p id="__p7">Total of 216 highly conserved (&#x0003e;70%) siRNA targets identified in this study are listed in Additional file <a href="#MOESM3" rid="MOESM3" class=" media">3</a>. In mammalian RNAi, the efficacy of each siRNA varies markedly depending on its sequence. According to our guidelines for the selection of effective siRNAs [<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351222">11</a>, <a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351217">12</a>], 31 out of 216 siRNAs were predicted to be functional. Similarly, 30 and 44 siRNAs are functional according to the algorithms reported by Reynolds <em>et al</em>. [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351215">13</a>], and Amarzguioui <em>et al</em>. [<a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351231">14</a>], respectively (Additional file <a href="#MOESM3" rid="MOESM3" class=" media">3</a>). This suggests that only a limited fraction of 21-mers is best suited for use as functional antiviral siRNAs.</p><p id="__p8">For the functional validation, 23 siRNAs from Additional file <a href="#MOESM3" rid="MOESM3" class=" media">3</a>, and 18 additional siRNAs targeting moderately-conserved regions were selected based on the following criteria: (I) predicted to be functional by the algorithm of Ui-Tei <em>et al</em>. [<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351228">11</a>, <a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351218">12</a>], and (II) the sequence has perfect identity with pNL4-3 (GenBank <a id="__tag_845351235" class="tag_hotlink" href="/nuccore/M19921" ref="/nuccore/M19921"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"M19921","term_id":"296556485","term_text":"M19921"}}</span>M19921</a>). The 41 siRNA sequences selected and their target sites are detailed in Additional file <a href="#MOESM4" rid="MOESM4" class=" media">4</a>. We first tested the efficacy of each siRNA using target mRNA cleavage assay (Additional file <a href="#MOESM5" rid="MOESM5" class=" media">5</a> and [<a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351211">15</a>]). Briefly, a vector expressing reporter mRNA that contains the siRNA target site was cotransfected into HeLa cells with the corresponding siRNA, and the mRNA cleavage activity of the siRNA was evaluated by measuring the quantity of surviving mRNA using real-time RT-PCR. This assay allows us to directly monitor the sequence-dependent potency of siRNA itself, without being affected by the differences in target gene expression level or target secondary structures. The result showed that 39 out of the 41 siRNAs gave &#x0003e;60% silencing at 5 nM (Figure <a href="/pmc/articles/PMC2204037/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2,</span></span><span>2</span></a>, rightmost panel). si4794 and si4888 were not functional, probably due to the long consecutive Gs in si4794 and internal palindromes (AAAAUUUU) in si4888 [<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351226">11</a>, <a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351230">13</a>].</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC2204037/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140168862648544" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12977_2007_Article_809_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12977_2007_Article_809_Fig2_HTML.jpg" src="/pmc/articles/PMC2204037/bin/12977_2007_Article_809_Fig2_HTML.jpg" /></div><div id="largeobj_idm140168862648544" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2204037/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC2204037/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p9"><strong>Validation of 41 siRNAs</strong>. The antiviral efficacy of each siRNA was tested against four HIV-1 infectious molecular clones: pNL4-2 (subtype B); 95MM-yIDU106 (subtype B\'); 93IN101 (subtype C); or 93JP-NH1 (CRF01_AE). The potency of each siRNA was tested using the target mRNA cleavage assay (rightmost panel). The ability of each siRNA to cleave its target was evaluated by the target mRNA cleavage assay.</p></div></div></div><p id="__p10">Next, siRNAs were evaluated for their antiviral efficacy against three evolutionary-distant groups of HIV-1: subtypes B and B\' (Thailand variant of subtype B [<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351212">16</a>]); subtype C; and CRF01_AE. Each siRNA was cotransfected into HeLa cells at 5 nM with one of the four infectious molecular clones: pNL4-3 (subtype B); 95MM-yIDU106 (subtype B\'); 93IN101 (subtype C); or 93JP-NH1 (CRF01_AE). Culture supernatants were collected 48 h after transfection and the viral reverse transcriptase activity was measured (Additional file <a href="#MOESM5" rid="MOESM5" class=" media">5</a> and [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351214">17</a>]). The results show that 26 of the 41 siRNAs effectively inhibited viral replication of all four strains by &#x0003e;80% (Figure <a href="/pmc/articles/PMC2204037/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2,</span></span><span>2</span></a>, marked with red or orange circles). Of the remaining 15 siRNAs, 13 of them (except si4794/4888) were shown to be functional in the target mRNA cleavage assay, and 12 of them (except si690/4794/4888) inhibited the replication of at least one viral strain by &#x0003e;80%, indicating that the designed siRNAs have the potential to induce RNAi. In several viral strains, nucleotide substitutions in their target sites essentially abolished the inhibition of viral replication (Figure <a href="/pmc/articles/PMC2204037/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2,</span></span><span>2</span></a>, blue bars with arrowheads). However, mismatches near the ends of the target sites (see Additional file <a href="#MOESM6" rid="MOESM6" class=" media">6</a>) did not necessarily abolish the siRNA efficacy (Figure <a href="/pmc/articles/PMC2204037/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2,</span></span><span>2</span></a>, blue bars with asterisks). si689 and si690 did not inhibit viral replication even though these siRNAs perfectly matched to their target sites (confirmed by DNA sequencing of the infectious molecular clones). This is probably due to the stable secondary structure at the si689-690 target sites in both BMH (branched multiple hairpin) conformation and LDI (long distance interaction) conformation of the HIV-1 leader RNA [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351219">18</a>] (see Additional file <a href="#MOESM4" rid="MOESM4" class=" media">4</a>). It should be noted that the efficacy of si575 differed when targeting pNL4-3 and 93IN101. One possible explanation for this is the secondary structure differences among HIV-1 subtypes, which may alter the accessibility of the si575 target site.</p><p id="__p11" class="p p-last">The approach described here enabled us to select highly effective siRNAs against divergent HIV-1 strains at a high rate. The highly effective siRNAs (&#x0003e;90% inhibition) with maximal conservation (&#x0003e;70%) identified in our study include si521 (poly A site; 94% conservation), si764/770 (&#x003a8;; 88%), si510 (TAR/poly A; 84%), si2075 (ribosomal slip site; 70%), si2329/2330/2333 (protease region; 77%), and si4750/4751/4753 (integrase region; 71&#x02013;74%). These sites are found mostly in the 5\' LTR, protease, and integrase regions (Figure <a href="/pmc/articles/PMC2204037/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2).</span></span><span>2</span></a>). However, the extraordinarily high genetic diversity of HIV-1 obviously prevents us from designing a single siRNA that can nullify all HIV-1 strains currently circulating worldwide (Additional file <a href="#MOESM7" rid="MOESM7" class=" media">7</a>). One possible approach is to combine multiple siRNAs targeting different conserved regions [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351210">19</a>, <a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845351227">20</a>]. The siRNAs selected and validated in this study have the potential to target &#x0003e;99% of HIV-1 strains by combining only two siRNAs (Additional file <a href="#MOESM7" rid="MOESM7" class=" media">7</a>), and also considered to resist viral mutational escape. Our approach is expected to be highly applicable to therapeutic intervention for other pathogens of public health importance, including HCV, influenza virus, and SARS coronavirus, that are known to show high genetic diversity.</p></div><div id="__sec2" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="__sec2title">Electronic supplementary material</h2><!--/article/body/sec/--><div id="Sec2" class="sec sec-first-last"><p id="__p12" class="p p-first-last">\n</p><div class="sec suppmat" id="MOESM1"><div class="sup-box half_rhythm" id="idm140168861908416"><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl">Additional file 1: The list of 495 near full-length genome sequences of HIV-1 group M. (PDF 56 KB)</a><sup>(56K, pdf)</sup></div></div><p>\n</p><div class="sec suppmat" id="MOESM2"><div class="sup-box half_rhythm" id="idm140168860410656"><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl">Additional file 2: The list of published siRNA/shRNAs targeting HIV-1. (PDF 101 KB)</a><sup>(101K, pdf)</sup></div></div><p>\n</p><div class="sec suppmat" id="MOESM3"><div class="sup-box half_rhythm" id="idm140168860407968"><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl">Additional file 3: The list of highly conserved siRNA targets identified in this study. (PDF 44 KB)</a><sup>(44K, pdf)</sup></div></div><p>\n</p><div class="sec suppmat" id="MOESM4"><div class="sup-box half_rhythm" id="idm140168863944112"><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM4_ESM.pdf" data-ga-action="click_feat_suppl">Additional file 4: The siRNA sequences and their target sites. The sequences of 41 siRNAs and their target sites are shown. The siRNA numbers indicate the nucleotide position in HXB2 (GenBank K03455). The conservation level of each siRNA in HIV-1 group M sequence is depicted in color chart at the rightmost column. BMH (branched multiple hairpin) and LDI (long distance interaction) conformations of the HIV-1 leader RNA and siRNAs targeting them are shown. (PDF 34 KB)</a><sup>(34K, pdf)</sup></div></div><p>\n</p><div class="sec suppmat" id="MOESM5"><div class="sup-box half_rhythm" id="idm140168863940944"><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM5_ESM.pdf" data-ga-action="click_feat_suppl">Additional file 5: Supplementary materials and methods. (PDF 40 KB)</a><sup>(40K, pdf)</sup></div></div><p>\n</p><div class="sec suppmat" id="MOESM6"><div class="sup-box half_rhythm" id="idm140168897700288"><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM6_ESM.pdf" data-ga-action="click_feat_suppl">Additional file 6: Target sites of the 41 siRNAs used in this study. Sequence alignment of the target site from the four HIV-1 infectious molecular clones: pNL4-2 (subtype B); 95MM-yIDU106 (subtype B\'); 93IN101 (subtype C); or 93JP-NH1 (CRF01_AE). (PDF 22 KB)</a><sup>(22K, pdf)</sup></div></div><p>\n</p><div class="sec suppmat" id="MOESM7"><div class="sup-box half_rhythm" id="idm140168897697328"><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM7_ESM.pdf" data-ga-action="click_feat_suppl">Additional file 7: Coverage of HIV-1 group M by single siRNA or two siRNAs. (A) Coverage of HIV-1 group M by 41 siRNAs used in this study. (B) Coverage of HIV-1 group M by combining two siRNAs from above. Coverage was calculated by considering only the HIV-1 sequences which contain the corresponding regions. (PDF 17 KB)</a><sup>(17K, pdf)</sup></div></div><p>\n</p></div></div><div id="idm140168870175360" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140168870175360title">Acknowledgements</h2><div class="sec"><p id="__p27">This study was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to YN, KU-T, KS, and YT), the Ministry of Health, Labour and Welfare of Japan (to YT), and the Japan Health Sciences Foundation (to YT).</p></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Authors&#x02019; original submitted files for images</h3><p id="__p20" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM8"><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM8_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(2.6M, pdf)</sup></span><span class="sup-box" id="MOESM9"><a href="/pmc/articles/PMC2204037/bin/12977_2007_809_MOESM9_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(33K, pdf)</sup></span></p></div></div><div id="idm140168866935536" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140168866935536title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140168866935408"><p id="__p23" class="p p-first"><strong>Competing interests</strong></p><p id="__p24" class="p p-last">The author(s) declare that they have no competing interests.</p></p><p class="fn sec" id="idm140168870177008"><p id="__p25" class="p p-first"><strong>Authors\' contributions</strong></p><p id="__p26" class="p p-last">YN performed the computational analyses and the target mRNA cleavage assays, participated in the design of the study, and drafted the manuscript. KN and TO performed the viral replication assays. RU analyzed the data. KU-T participated in the target mRNA cleavage assays, and was involved in critically revising the manuscript. KS and YT supervised the entire study and wrote the manuscript.</p></p></div></div><div id="idm140168861107408aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140168861107408aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Yuki Naito, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.iANR@otian-y" class="oemail">pj.iANR@otian-y</a></span>.</p><p><span class="fm-affl">Kyoko Nohtomi, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.og.hin@imoton" class="oemail">pj.og.hin@imoton</a></span>.</p><p><span class="fm-affl">Toshinari Onogi, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.og.hin@tigono" class="oemail">pj.og.hin@tigono</a></span>.</p><p><span class="fm-affl">Rie Uenishi, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.og.hin@rihsineu" class="oemail">pj.og.hin@rihsineu</a></span>.</p><p><span class="fm-affl">Kumiko Ui-Tei, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ca.oykot-u.s.mehcoib@ietk" class="oemail">pj.ca.oykot-u.s.mehcoib@ietk</a></span>.</p><p><span class="fm-affl">Kaoru Saigo, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ca.oykot-u.s.mehcoib@ogias" class="oemail">pj.ca.oykot-u.s.mehcoib@ogias</a></span>.</p><p><span class="fm-affl">Yutaka Takebe, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.og.hin@ebekat" class="oemail">pj.og.hin@ebekat</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in <em>Caenorhabditis elegans</em>. <span><span class="ref-journal">Nature. </span>1998;<span class="ref-vol">391</span>:806\xe2\x80\x93811. doi: 10.1038/35888.</span> [<a href="/pubmed/9486653" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F35888" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Potent+and+specific+genetic+interference+by+double-stranded+RNA+in+Caenorhabditis+elegans&amp;author=A+Fire&amp;author=S+Xu&amp;author=MK+Montgomery&amp;author=SA+Kostas&amp;author=SE+Driver&amp;volume=391&amp;publication_year=1998&amp;pages=806-811&amp;pmid=9486653&amp;doi=10.1038/35888&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. <span><span class="ref-journal">Nature. </span>2004;<span class="ref-vol">431</span>:371\xe2\x80\x93378. doi: 10.1038/nature02870.</span> [<a href="/pubmed/15372045" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnature02870" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Unlocking+the+potential+of+the+human+genome+with+RNA+interference&amp;author=GJ+Hannon&amp;author=JJ+Rossi&amp;volume=431&amp;publication_year=2004&amp;pages=371-378&amp;pmid=15372045&amp;doi=10.1038/nature02870&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Nielsen MH, Pedersen FS, Kjems J. Molecular strategies to inhibit HIV-1 replication. <span><span class="ref-journal">Retrovirology. </span>2005;<span class="ref-vol">2</span>:10. doi: 10.1186/1742-4690-2-10.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC553987/">PMC free article</a>]</span> [<a href="/pubmed/15715913" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1742-4690-2-10" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Retrovirology&amp;title=Molecular+strategies+to+inhibit+HIV-1+replication&amp;author=MH+Nielsen&amp;author=FS+Pedersen&amp;author=J+Kjems&amp;volume=2&amp;publication_year=2005&amp;pages=10&amp;pmid=15715913&amp;doi=10.1186/1742-4690-2-10&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Leonard JN, Schaffer DV. Antiviral RNAi therapy: emerging approaches for hitting a moving target. <span><span class="ref-journal">Gene Ther. </span>2006;<span class="ref-vol">13</span>:532\xe2\x80\x93540. doi: 10.1038/sj.gt.3302645.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7091878/">PMC free article</a>]</span> [<a href="/pubmed/16177819" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fsj.gt.3302645" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Ther&amp;title=Antiviral+RNAi+therapy:+emerging+approaches+for+hitting+a+moving+target&amp;author=JN+Leonard&amp;author=DV+Schaffer&amp;volume=13&amp;publication_year=2006&amp;pages=532-540&amp;pmid=16177819&amp;doi=10.1038/sj.gt.3302645&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Boden D, Pusch O, Lee F, Tucker L, Ramratnam B. Human immunodeficiency virus type 1 escape from RNA interference. <span><span class="ref-journal">J Virol. </span>2003;<span class="ref-vol">77</span>:11531\xe2\x80\x9311535. doi: 10.1128/JVI.77.21.11531-11535.2003.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC229317/">PMC free article</a>]</span> [<a href="/pubmed/14557638" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.77.21.11531-11535.2003" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Human+immunodeficiency+virus+type+1+escape+from+RNA+interference&amp;author=D+Boden&amp;author=O+Pusch&amp;author=F+Lee&amp;author=L+Tucker&amp;author=B+Ramratnam&amp;volume=77&amp;publication_year=2003&amp;pages=11531-11535&amp;pmid=14557638&amp;doi=10.1128/JVI.77.21.11531-11535.2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Das AT, Brummelkamp TR, Westerhout EM, Vink M, Madiredjo M, Bernards R, Berkhout B. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. <span><span class="ref-journal">J Virol. </span>2004;<span class="ref-vol">78</span>:2601\xe2\x80\x932605. doi: 10.1128/JVI.78.5.2601-2605.2004.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC369246/">PMC free article</a>]</span> [<a href="/pubmed/14963165" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.78.5.2601-2605.2004" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Human+immunodeficiency+virus+type+1+escapes+from+RNA+interference-mediated+inhibition&amp;author=AT+Das&amp;author=TR+Brummelkamp&amp;author=EM+Westerhout&amp;author=M+Vink&amp;author=M+Madiredjo&amp;volume=78&amp;publication_year=2004&amp;pages=2601-2605&amp;pmid=14963165&amp;doi=10.1128/JVI.78.5.2601-2605.2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. <span><span class="ref-journal">Nucleic Acids Res. </span>2005;<span class="ref-vol">33</span>:796\xe2\x80\x93804. doi: 10.1093/nar/gki220.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC548362/">PMC free article</a>]</span> [<a href="/pubmed/15687388" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fnar%2Fgki220" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=HIV-1+can+escape+from+RNA+interference+by+evolving+an+alternative+structure+in+its+RNA+genome&amp;author=EM+Westerhout&amp;author=M+Ooms&amp;author=M+Vink&amp;author=AT+Das&amp;author=B+Berkhout&amp;volume=33&amp;publication_year=2005&amp;pages=796-804&amp;pmid=15687388&amp;doi=10.1093/nar/gki220&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Naito Y, Ui-Tei K, Nishikawa T, Takebe Y, Saigo K. siVirus: web-based antiviral siRNA design software for highly divergent viral sequences. <span><span class="ref-journal">Nucleic Acids Res. </span>2006;<span class="ref-vol">34</span>:W448\xe2\x80\x93W450. doi: 10.1093/nar/gkl214.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1538817/">PMC free article</a>]</span> [<a href="/pubmed/16845046" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fnar%2Fgkl214" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=siVirus:+web-based+antiviral+siRNA+design+software+for+highly+divergent+viral+sequences&amp;author=Y+Naito&amp;author=K+Ui-Tei&amp;author=T+Nishikawa&amp;author=Y+Takebe&amp;author=K+Saigo&amp;volume=34&amp;publication_year=2006&amp;pages=W448-W450&amp;pmid=16845046&amp;doi=10.1093/nar/gkl214&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">ter Brake O, Berkhout B. A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs. <span><span class="ref-journal">J RNAi Gene Silencing. </span>2005;<span class="ref-vol">1</span>:56\xe2\x80\x9365.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2737200/">PMC free article</a>]</span> [<a href="/pubmed/19771206" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+RNAi+Gene+Silencing&amp;title=A+novel+approach+for+inhibition+of+HIV-1+by+RNA+interference:+counteracting+viral+escape+with+a+second+generation+of+siRNAs&amp;author=O+ter+Brake&amp;author=B+Berkhout&amp;volume=1&amp;publication_year=2005&amp;pages=56-65&amp;pmid=19771206&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Beerens N, Groot F, Berkhout B. Initiation of HIV-1 reverse transcription is regulated by a primer activation signal. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>:31247\xe2\x80\x9331256. doi: 10.1074/jbc.M102441200.</span> [<a href="/pubmed/11384976" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1074%2Fjbc.M102441200" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Initiation+of+HIV-1+reverse+transcription+is+regulated+by+a+primer+activation+signal&amp;author=N+Beerens&amp;author=F+Groot&amp;author=B+Berkhout&amp;volume=276&amp;publication_year=2001&amp;pages=31247-31256&amp;pmid=11384976&amp;doi=10.1074/jbc.M102441200&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, Juni A, Ueda R, Saigo K. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. <span><span class="ref-journal">Nucleic Acids Res. </span>2004;<span class="ref-vol">32</span>:936\xe2\x80\x93948. doi: 10.1093/nar/gkh247.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC373388/">PMC free article</a>]</span> [<a href="/pubmed/14769950" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fnar%2Fgkh247" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=Guidelines+for+the+selection+of+highly+effective+siRNA+sequences+for+mammalian+and+chick+RNA+interference&amp;author=K+Ui-Tei&amp;author=Y+Naito&amp;author=F+Takahashi&amp;author=T+Haraguchi&amp;author=H+Ohki-Hamazaki&amp;volume=32&amp;publication_year=2004&amp;pages=936-948&amp;pmid=14769950&amp;doi=10.1093/nar/gkh247&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Naito Y, Yamada T, Ui-Tei K, Morishita S, Saigo K. siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. <span><span class="ref-journal">Nucleic Acids Res. </span>2004;<span class="ref-vol">32</span>:W124\xe2\x80\x93W129. doi: 10.1093/nar/gkh442.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC441580/">PMC free article</a>]</span> [<a href="/pubmed/15215364" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fnar%2Fgkh442" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=siDirect:+highly+effective,+target-specific+siRNA+design+software+for+mammalian+RNA+interference&amp;author=Y+Naito&amp;author=T+Yamada&amp;author=K+Ui-Tei&amp;author=S+Morishita&amp;author=K+Saigo&amp;volume=32&amp;publication_year=2004&amp;pages=W124-W129&amp;pmid=15215364&amp;doi=10.1093/nar/gkh442&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. <span><span class="ref-journal">Nat Biotechnol. </span>2004;<span class="ref-vol">22</span>:326\xe2\x80\x93330. doi: 10.1038/nbt936.</span> [<a href="/pubmed/14758366" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnbt936" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;title=Rational+siRNA+design+for+RNA+interference&amp;author=A+Reynolds&amp;author=D+Leake&amp;author=Q+Boese&amp;author=S+Scaringe&amp;author=WS+Marshall&amp;volume=22&amp;publication_year=2004&amp;pages=326-330&amp;pmid=14758366&amp;doi=10.1038/nbt936&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Amarzguioui M, Prydz H. An algorithm for selection of functional siRNA sequences. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2004;<span class="ref-vol">316</span>:1050\xe2\x80\x931058. doi: 10.1016/j.bbrc.2004.02.157.</span> [<a href="/pubmed/15044091" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.bbrc.2004.02.157" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=An+algorithm+for+selection+of+functional+siRNA+sequences&amp;author=M+Amarzguioui&amp;author=H+Prydz&amp;volume=316&amp;publication_year=2004&amp;pages=1050-1058&amp;pmid=15044091&amp;doi=10.1016/j.bbrc.2004.02.157&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Ui-Tei K, Naito Y, Saigo K. Guidelines for the selection of effective short-interfering RNA sequences for functional genomics. <span><span class="ref-journal">Methods Mol Biol. </span>2007;<span class="ref-vol">361</span>:201\xe2\x80\x93216.</span> [<a href="/pubmed/17172713" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods+Mol+Biol&amp;title=Guidelines+for+the+selection+of+effective+short-interfering+RNA+sequences+for+functional+genomics&amp;author=K+Ui-Tei&amp;author=Y+Naito&amp;author=K+Saigo&amp;volume=361&amp;publication_year=2007&amp;pages=201-216&amp;pmid=17172713&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Kalish ML, Baldwin A, Raktham S, Wasi C, Luo CC, Schochetman G, Mastro TD, Young N, Vanichseni S, R&#x000fc;bsamen-Waigmann H, von Briesen H, Mullins JI, Delwart E, Herring B, Esparza J, Heyward WL, Osmanov S. The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials. <span><span class="ref-journal">AIDS. </span>1995;<span class="ref-vol">9</span>:851\xe2\x80\x93857. doi: 10.1097/00002030-199508000-00004.</span> [<a href="/pubmed/7576318" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F00002030-199508000-00004" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AIDS&amp;title=The+evolving+molecular+epidemiology+of+HIV-1+envelope+subtypes+in+injecting+drug+users+in+Bangkok,+Thailand:+implications+for+HIV+vaccine+trials&amp;author=ML+Kalish&amp;author=A+Baldwin&amp;author=S+Raktham&amp;author=C+Wasi&amp;author=CC+Luo&amp;volume=9&amp;publication_year=1995&amp;pages=851-857&amp;pmid=7576318&amp;doi=10.1097/00002030-199508000-00004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, Martin MA. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. <span><span class="ref-journal">J Virol. </span>1988;<span class="ref-vol">62</span>:139\xe2\x80\x93147.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC250512/">PMC free article</a>]</span> [<a href="/pubmed/3257102" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=In+vitro+mutagenesis+identifies+a+region+within+the+envelope+gene+of+the+human+immunodeficiency+virus+that+is+critical+for+infectivity&amp;author=RL+Willey&amp;author=DH+Smith&amp;author=LA+Lasky&amp;author=TS+Theodore&amp;author=PL+Earl&amp;volume=62&amp;publication_year=1988&amp;pages=139-147&amp;pmid=3257102&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Huthoff H, Berkhout B. Two alternating structures of the HIV-1 leader RNA. <span><span class="ref-journal">RNA. </span>2001;<span class="ref-vol">7</span>:143\xe2\x80\x93157. doi: 10.1017/S1355838201001881.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1370064/">PMC free article</a>]</span> [<a href="/pubmed/11214176" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1017%2FS1355838201001881" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=RNA&amp;title=Two+alternating+structures+of+the+HIV-1+leader+RNA&amp;author=H+Huthoff&amp;author=B+Berkhout&amp;volume=7&amp;publication_year=2001&amp;pages=143-157&amp;pmid=11214176&amp;doi=10.1017/S1355838201001881&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Nishitsuji H, Kohara M, Kannagi M, Masuda T. Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration. <span><span class="ref-journal">J Virol. </span>2006;<span class="ref-vol">80</span>:7658\xe2\x80\x937666. doi: 10.1128/JVI.00078-06.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1563699/">PMC free article</a>]</span> [<a href="/pubmed/16840344" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.00078-06" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Effective+suppression+of+human+immunodeficiency+virus+type+1+through+a+combination+of+short-+or+long-hairpin+RNAs+targeting+essential+sequences+for+retroviral+integration&amp;author=H+Nishitsuji&amp;author=M+Kohara&amp;author=M+Kannagi&amp;author=T+Masuda&amp;volume=80&amp;publication_year=2006&amp;pages=7658-7666&amp;pmid=16840344&amp;doi=10.1128/JVI.00078-06&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">ter Brake O, Konstantinova P, Ceylan M, Berkhout B. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. <span><span class="ref-journal">Mol Ther. </span>2006;<span class="ref-vol">14</span>:883\xe2\x80\x93892. doi: 10.1016/j.ymthe.2006.07.007.</span> [<a href="/pubmed/16959541" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.ymthe.2006.07.007" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Silencing+of+HIV-1+with+RNA+interference:+a+multiple+shRNA+approach&amp;author=O+ter+Brake&amp;author=P+Konstantinova&amp;author=M+Ceylan&amp;author=B+Berkhout&amp;volume=14&amp;publication_year=2006&amp;pages=883-892&amp;pmid=16959541&amp;doi=10.1016/j.ymthe.2006.07.007&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2204037&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2204037/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2204037/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2204037/pdf/12977_2007_Article_809.pdf">PDF (1.3M)</a></li> | <li><a href="#" data-citationid="PMC2204037" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2204037%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2204037%2F&amp;text=Optimal%20design%20and%20validation%20of%20antiviral%20siRNA%20for%20targeting%20HIV-1"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2204037%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="17996047" data-aiid="7100204" data-aid="2204037" data-iid="354895" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC2204037" data-md5="e3073e3f3496cf11c3ff5481c442abeb"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:34:49-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A34FAE999BF41000000000B360B34&amp;ncbi_session=8A1A34FAE99B0791_2870SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2204037%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2204037/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A34FAE99B0791_2870SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'